Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Piper Sandler remains 'apprehensive' on Integra LifeSciences after Q2 revenue » 20:24
07/09/20
07/09
20:24
07/09/20
20:24
IART

Integra LifeSciences

$46.22 /

-0.555 (-1.19%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien keeps his Neutral rating and $53 price target on Integra LifeSciences after the company pre-announced Q2 revenue above consensus driven by the return of elective procedure as many states lifted Shelter in Place guidance. While the sequential improvement is encouraging though, the company is not comfortably quantifying the impact of the pandemic into the 2nd half of the year as the situation remains "fairly ambiguous", the analyst tells investors in a research note.

ShowHide Related Items >><<
IART Integra LifeSciences
$46.22 /

-0.555 (-1.19%)

IART Integra LifeSciences
$46.22 /

-0.555 (-1.19%)

05/27/20
Fly Intel: Top five analyst initiations
05/27/20 Citi
Integra LifeSciences initiated with a Neutral at Citi
05/21/20 Piper Sandler
Early diligence on new Tactile Systems CEO very positive, says Piper Sandler
05/08/20 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
IART Integra LifeSciences
$46.22 /

-0.555 (-1.19%)

IART Integra LifeSciences
$46.22 /

-0.555 (-1.19%)

On The Fly
Fly Intel: After-Hours Movers » 19:02
07/09/20
07/09
19:02
07/09/20
19:02
SLP

Simulations Plus

$63.55 /

+1.57 (+2.53%)

, PSMT

PriceSmart

$60.38 /

+0.895 (+1.50%)

, MATX

Matson

$27.46 /

-0.69 (-2.45%)

, ZIOP

Ziopharm

$3.24 /

+0.04 (+1.25%)

, IART

Integra LifeSciences

$46.22 /

-0.555 (-1.19%)

, WDFC

WD-40

$200.59 /

-2.48 (-1.22%)

, FC

Franklin Covey

$19.18 /

-1.125 (-5.54%)

, KERN

Akerna

$7.25 /

-0.21 (-2.82%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
ZIOP Ziopharm
$3.24 /

+0.04 (+1.25%)

WDFC WD-40
$200.59 /

-2.48 (-1.22%)

SLP Simulations Plus
$63.55 /

+1.57 (+2.53%)

PSMT PriceSmart
$60.38 /

+0.895 (+1.50%)

MATX Matson
$27.46 /

-0.69 (-2.45%)

KERN Akerna
$7.25 /

-0.21 (-2.82%)

IART Integra LifeSciences
$46.22 /

-0.555 (-1.19%)

FC Franklin Covey
$19.18 /

-1.125 (-5.54%)

SLP Simulations Plus
$63.55 /

+1.57 (+2.53%)

06/08/20 Craig-Hallum
Simulations Plus price target raised to $56 from $40 at Craig-Hallum
01/06/20 Craig-Hallum
Simulations Plus initiated with a Buy at Craig-Hallum
PSMT PriceSmart
$60.38 /

+0.895 (+1.50%)

05/08/20 Scotiabank
Scotiabank downgrades PriceSmart amid COVID-19 restrictions
05/08/20 Scotiabank
PriceSmart downgraded to Sector Perform from Outperform at Scotiabank
09/23/19 Kansas City Capital
PriceSmart downgraded to Perform from Outperform at Kansas City Capital
07/18/19
Fly Intel: Top five analyst upgrades
MATX Matson
$27.46 /

-0.69 (-2.45%)

04/06/20 Stephens
Matson downgraded to Equal Weight from Overweight at Stephens
02/27/20 Stifel
Matson upgraded to Buy from Hold at Stifel
ZIOP Ziopharm
$3.24 /

+0.04 (+1.25%)

06/19/20 Jefferies
Ziopharm initiated with a Buy at Jefferies
05/11/20 H.C. Wainwright
Ziopharm price target lowered to $5.50 from $6.50 at H.C. Wainwright
03/04/20
Fly Intel: Top five analyst initiations
03/04/20 Cantor Fitzgerald
Ziopharm initiated with Overweight, $6 price target at Cantor Fitzgerald
IART Integra LifeSciences
$46.22 /

-0.555 (-1.19%)

05/27/20
Fly Intel: Top five analyst initiations
05/27/20 Citi
Integra LifeSciences initiated with a Neutral at Citi
05/21/20 Piper Sandler
Early diligence on new Tactile Systems CEO very positive, says Piper Sandler
05/08/20 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
WDFC WD-40
$200.59 /

-2.48 (-1.22%)

03/27/20 DA Davidson
WD-40 upgraded to Buy from Neutral at DA Davidson
03/27/20 DA Davidson
WD-40 upgraded to Buy from Neutral at DA Davidson
01/07/20 DA Davidson
WD-40 downgraded to Neutral from Buy at DA Davidson
01/07/20 DA Davidson
WD-40 downgraded to Neutral from Buy at DA Davidson
FC Franklin Covey
$19.18 /

-1.125 (-5.54%)

04/03/20 Roth Capital
Franklin Covey price target lowered to $28 from $51 at Roth Capital
03/30/20 B. Riley FBR
Franklin Covey price target lowered to $32 from $45 at B. Riley FBR
01/30/20
Franklin Covey management to meet with Roth Capital
KERN Akerna
$7.25 /

-0.21 (-2.82%)

ZIOP Ziopharm
$3.24 /

+0.04 (+1.25%)

WDFC WD-40
$200.59 /

-2.48 (-1.22%)

SLP Simulations Plus
$63.55 /

+1.57 (+2.53%)

PSMT PriceSmart
$60.38 /

+0.895 (+1.50%)

MATX Matson
$27.46 /

-0.69 (-2.45%)

KERN Akerna
$7.25 /

-0.21 (-2.82%)

IART Integra LifeSciences
$46.22 /

-0.555 (-1.19%)

FC Franklin Covey
$19.18 /

-1.125 (-5.54%)

  • 05
    Feb
WDFC WD-40
$200.59 /

-2.48 (-1.22%)

WDFC WD-40
$200.59 /

-2.48 (-1.22%)

PSMT PriceSmart
$60.38 /

+0.895 (+1.50%)

KERN Akerna
$7.25 /

-0.21 (-2.82%)

ZIOP Ziopharm
$3.24 /

+0.04 (+1.25%)

WDFC WD-40
$200.59 /

-2.48 (-1.22%)

SLP Simulations Plus
$63.55 /

+1.57 (+2.53%)

PSMT PriceSmart
$60.38 /

+0.895 (+1.50%)

KERN Akerna
$7.25 /

-0.21 (-2.82%)

FC Franklin Covey
$19.18 /

-1.125 (-5.54%)

Earnings
Integra LifeSciences reports preliminary Q2 revenue $254M-$256M » 16:18
07/09/20
07/09
16:18
07/09/20
16:18
IART

Integra LifeSciences

$46.32 /

-0.455 (-0.97%)

Consensus $240.49M.…

Consensus $240.49M. Throughout the quarter, monthly sales performance improved sequentially due to the resumption of non-emergent surgical procedures and the easing of shelter-in-place restrictions. The company's average daily sales in the month of June were down approximately 15% when compared to the average daily sales rate for Q2 of 2019.

ShowHide Related Items >><<
IART Integra LifeSciences
$46.32 /

-0.455 (-0.97%)

IART Integra LifeSciences
$46.32 /

-0.455 (-0.97%)

05/27/20
Fly Intel: Top five analyst initiations
05/27/20 Citi
Integra LifeSciences initiated with a Neutral at Citi
05/21/20 Piper Sandler
Early diligence on new Tactile Systems CEO very positive, says Piper Sandler
05/08/20 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
IART Integra LifeSciences
$46.32 /

-0.455 (-0.97%)

Over a month ago
Initiation
Fly Intel: Top five analyst initiations » 10:06
05/27/20
05/27
10:06
05/27/20
10:06
CMG

Chipotle

$994.00 /

-24.98 (-2.45%)

, DAVA

Endava

$48.07 /

-0.395 (-0.82%)

, IART

Integra LifeSciences

$52.45 /

+0.47 (+0.90%)

, FRPT

Freshpet

$70.51 /

-0.26 (-0.37%)

, PING

Ping Identity

$25.28 /

-2.41 (-8.70%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chipotle (CMG) initiated with a Hold at Deutsche Bank. 2. Endava (DAVA) initiated with an Outperform at Wedbush. 3. Integra LifeSciences (IART) initiated with a Neutral at Citi. 4. Freshpet (FRPT) initiated with a Buy at Jefferies. 5. Ping Identity (PING) initiated with an Overweight at Piper Sandler. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
PING Ping Identity
$25.28 /

-2.41 (-8.70%)

IART Integra LifeSciences
$52.45 /

+0.47 (+0.90%)

FRPT Freshpet
$70.51 /

-0.26 (-0.37%)

DAVA Endava
$48.07 /

-0.395 (-0.82%)

CMG Chipotle
$994.00 /

-24.98 (-2.45%)

CMG Chipotle
$994.00 /

-24.98 (-2.45%)

05/26/20 Deutsche Bank
Deutsche Bank starts Chipotle at Hold despite 'compelling' story
05/26/20 Deutsche Bank
Chipotle initiated with a Hold at Deutsche Bank
05/26/20 JPMorgan
Chipotle price target raised to $845 from $630 at JPMorgan
05/14/20 Piper Sandler
Chipotle price target raised to $1,100 from $850 at Piper Sandler
DAVA Endava
$48.07 /

-0.395 (-0.82%)

05/27/20 Wedbush
Wedbush bullish on Endava, initiates with an Outperform
05/26/20 Wedbush
Endava initiated with an Outperform at Wedbush
02/14/20 Cantor Fitzgerald
Endava price target raised to $56 from $46 at Cantor Fitzgerald
12/03/19 Needham
Endava price target raised to $53 from $50 at Needham
IART Integra LifeSciences
$52.45 /

+0.47 (+0.90%)

05/27/20 Citi
Integra LifeSciences initiated with a Neutral at Citi
05/21/20 Piper Sandler
Early diligence on new Tactile Systems CEO very positive, says Piper Sandler
05/08/20 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
04/08/20 BTIG
Integra LifeSciences price target lowered to $59 from $70 at BTIG
FRPT Freshpet
$70.51 /

-0.26 (-0.37%)

05/27/20 Jefferies
Freshpet initiated with a Buy at Jefferies
05/27/20 Jefferies
Freshpet initiated with a Buy at Jefferies
05/11/20
Fly Intel: Top five analyst initiations
05/11/20 Citi
Freshpet initiated with a Neutral at Citi
PING Ping Identity
$25.28 /

-2.41 (-8.70%)

05/27/20 Piper Sandler
Ping Identity initiated with an Overweight at Piper Sandler
04/16/20
Ping Identity initiated with a Neutral at Dougherty
03/27/20 Citi
Citi opens one positive, four negative catalyst watches in Software
03/27/20 BTIG
Ping Identity initiated with a Buy at BTIG
PING Ping Identity
$25.28 /

-2.41 (-8.70%)

IART Integra LifeSciences
$52.45 /

+0.47 (+0.90%)

FRPT Freshpet
$70.51 /

-0.26 (-0.37%)

DAVA Endava
$48.07 /

-0.395 (-0.82%)

CMG Chipotle
$994.00 /

-24.98 (-2.45%)

CMG Chipotle
$994.00 /

-24.98 (-2.45%)

PING Ping Identity
$25.28 /

-2.41 (-8.70%)

FRPT Freshpet
$70.51 /

-0.26 (-0.37%)

CMG Chipotle
$994.00 /

-24.98 (-2.45%)

PING Ping Identity
$25.28 /

-2.41 (-8.70%)

CMG Chipotle
$994.00 /

-24.98 (-2.45%)

Initiation
Integra LifeSciences initiated with a Neutral at Citi » 06:17
05/27/20
05/27
06:17
05/27/20
06:17
IART

Integra LifeSciences

$51.98 /

+1.99 (+3.98%)

Citi analyst Joanne…

Citi analyst Joanne Wuensch initiated coverage of Integra LifeSciences with a Neutral rating and $54 price target. The company's transformation will increase shareholder value, but the current environment and relative valuation warrant a Neutral rating, Wuensch tells investors in a research note.

ShowHide Related Items >><<
IART Integra LifeSciences
$51.98 /

+1.99 (+3.98%)

IART Integra LifeSciences
$51.98 /

+1.99 (+3.98%)

05/21/20 Piper Sandler
Early diligence on new Tactile Systems CEO very positive, says Piper Sandler
05/08/20 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
04/08/20 BTIG
Integra LifeSciences price target lowered to $59 from $70 at BTIG
04/07/20 Piper Sandler
Piper says risk-reward setup for Integra 'fairly balanced' prior to COVID-19
IART Integra LifeSciences
$51.98 /

+1.99 (+3.98%)

Conference/Events
Integra LifeSciences participates in a conference call with JMP Securities » 04:55
05/27/20
05/27
04:55
05/27/20
04:55
IART

Integra LifeSciences

$51.98 /

+1.99 (+3.98%)

Conference call with…

Conference call with management will be held on May 27 hosted by JMP Securities.

ShowHide Related Items >><<
IART Integra LifeSciences
$51.98 /

+1.99 (+3.98%)

IART Integra LifeSciences
$51.98 /

+1.99 (+3.98%)

05/21/20 Piper Sandler
Early diligence on new Tactile Systems CEO very positive, says Piper Sandler
05/08/20 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
04/08/20 BTIG
Integra LifeSciences price target lowered to $59 from $70 at BTIG
04/07/20 Piper Sandler
Piper says risk-reward setup for Integra 'fairly balanced' prior to COVID-19
IART Integra LifeSciences
$51.98 /

+1.99 (+3.98%)

Recommendations
Early diligence on new Tactile Systems CEO very positive, says Piper Sandler » 19:48
05/21/20
05/21
19:48
05/21/20
19:48
TCMD

Tactile Systems

$47.18 /

-3.46 (-6.83%)

, IART

Integra LifeSciences

$49.81 /

+0.28 (+0.57%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien keeps his Overweight rating and $70 price target on Tactile Systems (TCMD) after the company announced a "much anticipated" replacement of its CEO Jarry Mattys with Dan Reuvers. The analyst notes that Reuvers has "big shoes to fill", but his early diligence on the incoming executive has been "very positive". O'Brien adds that the CEO announcement could alleviate one of investors' concerns about the stock, as his willingness to leave Integra LifeSciences (IART) suggests "comfort on the outlook for the ongoing Qui Tam lawsuit".

ShowHide Related Items >><<
TCMD Tactile Systems
$47.18 /

-3.46 (-6.83%)

IART Integra LifeSciences
$49.81 /

+0.28 (+0.57%)

TCMD Tactile Systems
$47.18 /

-3.46 (-6.83%)

04/07/20 BTIG
Tactile Systems price target lowered to $63 from $72 at BTIG
04/06/20 Piper Sandler
Piper Sandler remains 'constructive' on Tactile Systems after 'solid' Q1 results
01/20/20 Piper Sandler
Lawsuit may drag out into 2021, impact on Tactile 'modest,' says Piper Sandler
01/13/20 Piper Sandler
Tactile Systems momentum to benefit further results, says Piper Sandler
IART Integra LifeSciences
$49.81 /

+0.28 (+0.57%)

05/08/20 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
04/08/20 BTIG
Integra LifeSciences price target lowered to $59 from $70 at BTIG
04/07/20 Piper Sandler
Piper says risk-reward setup for Integra 'fairly balanced' prior to COVID-19
04/02/20 SunTrust
Integra LifeSciences initiated with a Buy at SunTrust
TCMD Tactile Systems
$47.18 /

-3.46 (-6.83%)

IART Integra LifeSciences
$49.81 /

+0.28 (+0.57%)

Conference/Events
Integra LifeSciences participates in a conference call with JMP Securities » 15:15
05/21/20
05/21
15:15
05/21/20
15:15
IART

Integra LifeSciences

$49.92 /

+0.39 (+0.79%)

Conference call with…

Conference call with management will be held on May 27 hosted by JMP Securities.

ShowHide Related Items >><<
IART Integra LifeSciences
$49.92 /

+0.39 (+0.79%)

IART Integra LifeSciences
$49.92 /

+0.39 (+0.79%)

05/08/20 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
04/08/20 BTIG
Integra LifeSciences price target lowered to $59 from $70 at BTIG
04/07/20 Piper Sandler
Piper says risk-reward setup for Integra 'fairly balanced' prior to COVID-19
04/02/20 SunTrust
Integra LifeSciences initiated with a Buy at SunTrust
IART Integra LifeSciences
$49.92 /

+0.39 (+0.79%)

Hot Stocks
Integra LifeSciences announces clinical results for Integra Bilayer Wound Matrix » 08:09
05/15/20
05/15
08:09
05/15/20
08:09
IART

Integra LifeSciences

$47.21 /

-0.085 (-0.18%)

Integra LifeSciences…

Integra LifeSciences Holding Corporation announced clinical and economic data on Integra Bilayer Wound Matrix (IBWM) in complex lower extremity reconstruction. This data from two retrospective studies was recently published by Stephen J. Kovach, M.D., FACS, and John P. Fischer, M.D., MPH, FACS, from the University of Pennsylvania Health System, in Plastic and Reconstructive Surgery, the official journal of the American Society of Plastic Surgeons. IBWM provides an environment where the body can rebuild the layers of the skin supporting the healing process. In areas of the body where range of motion is important, IBWM helps patients get back to functioning and living as they did before the wound occurred. Yesterday, 200 surgeons from around the world attended an Integra LifeSciences webinar "Efficient & Effective Ways to Manage Lower Extremity Wounds." During this webinar, Drs. Kovach and Fischer presented their recently published data and shared their insights and strategies to help address the efficiency of operating room time and prioritization of procedures as operating rooms start to reopen during the COVID-19 pandemic. The first clinical publication reviews the efficacy of the Integra Bilayer Wound Matrix for lower extremity soft tissue reconstruction. With 70% of the wounds successfully salvaged at the 180-day timepoint, the authors were able to identify success factors across patient selection and wound types. The second publication reviewed cost and resource utilization comparing Integra Bilayer Wound Matrix, Local Tissue Rearrangement and Free Flap. This study showed significantly longer surgery time at 85 and 408 minutes for LTR and FF respectively, compared with 50 minutes for Integra Bilayer Wound Matrix. It also reported more than double the length of stay in the hospital for both LTR and FF versus Integra Bilayer Wound Matrix. Lastly, total cost of the surgery was $53,492 for FF, $35,220 for LTR and $34,877 for Integra Bilayer Wound Matrix. Given the shorter operating time and the potential lower cost, Integra Bilayer Wound Matrix may represent an opportunity for patients, surgeons and hospitals during the current situation.

ShowHide Related Items >><<
IART Integra LifeSciences
$47.21 /

-0.085 (-0.18%)

IART Integra LifeSciences
$47.21 /

-0.085 (-0.18%)

05/08/20 JMP Securities
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities
04/08/20 BTIG
Integra LifeSciences price target lowered to $59 from $70 at BTIG
04/07/20 Piper Sandler
Piper says risk-reward setup for Integra 'fairly balanced' prior to COVID-19
04/02/20 SunTrust
Integra LifeSciences initiated with a Buy at SunTrust
IART Integra LifeSciences
$47.21 /

-0.085 (-0.18%)

Recommendations
Integra LifeSciences price target lowered to $65 from $75 at JMP Securities » 06:27
05/08/20
05/08
06:27
05/08/20
06:27
IART

Integra LifeSciences

$51.14 /

-0.55 (-1.06%)

JMP Securities analyst…

JMP Securities analyst David Turkaly lowered his price target on Integra LifeSciences and keeps an Outperform rating on the shares. The analyst contends that the company will still soon be in the position to deliver on its 5% organic revenue growth and its double-digit expected EPS increases, but until the outbreak of COVID-19 subsides, he sees this rate of growth being pushed out to the 2021 time frame at the earliest.

ShowHide Related Items >><<
IART Integra LifeSciences
$51.14 /

-0.55 (-1.06%)

04/08/20 BTIG
Integra LifeSciences price target lowered to $59 from $70 at BTIG
04/07/20 Piper Sandler
Piper says risk-reward setup for Integra 'fairly balanced' prior to COVID-19
04/02/20 SunTrust
Integra LifeSciences initiated with a Buy at SunTrust
04/02/20 SunTrust
Integra LifeSciences initiated with a Buy at SunTrust

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.